Author: Kimberly Luz
-
Exicure obtains a credit facility for up to $ 25.0 million
CHICAGO & CAMBRIDGE, Mass .– (BUSINESS WIRE) – Exicure, Inc. (Nasdaq: XCUR), a pioneer of gene regulation and immunotherapeutic drugs using spherical nucleic acid (SNA ™) ...
